Siham Ceballos
Informations personnelles
| Nom complet | Siham Ceballos |
| Genre | |
| Pays | SWITZERLAND |
| Canton | Vaud |
Voir le profil complet de Siham Ceballos ! C'est gratuit.
Vos collègues, votre réseau, vos clients et 50'000 membres sont sur rezonance.
Données professionnelles
| Entreprise-Organisation | Celgene |
| Fonction | Associate Director Medical Affairs Europe |
| Domaine d'activité | |
| Statut | |
| Position | |
| Biographie / CV | Academic and Pharmaceutical Industry Experience: Drug Development, Marketing, Business Development, Scientific and Medical Communication, Medical Affairs, KOL Portfolio in Oncology02.2010- PresentCelgene: Associate Director, Preclinical and Translational Research, EUR&D01.2009- 01.2010Celgene: Associate director, Medical Affairs, Europe, reporting to the Head of R&D Europe 08.2007- 01.2009Celgene: Associate director, Medical Affairs, Europe. Celgene start-up stage.Main Responsibility: create a European Medical Affairs Departmentand Build a European Medical affairs team (7 members). Reporting to the head of R&D and Clinical Operations in Europe10.2006- 08.2007Celgene start-up stage: Marketing Manager, Europe, within 3 members team reporting to the head of Marketing Europe. Pre-launch of the first Celgene product.01.2004- 11.2006Pfizer- France: National Medical Adviser, Oncology Business Unit, ParisContext: start-up of Oncology activities within Pfizer. I was the only non MD in a team of 5 MDs. oHeavy involvement in the pre-launch and launch of Sutent, a targeting therapie with a molecular biology based mechanism of action.oMember of Cross Functional, Business Development team for Anti-Angiogenic Agent SU11248 (Sutent): 2001 - 2002 Sanofi-Synthélabo: Marketing & Strategy Consultant, Project manager:2001 - 2002 WyethAyerst: Marketing & Strategy, Consultant 2001-2002INSERM, Ecole de Médecine, Paris: Scientist1998- 2001Ludwig Institute for Cancer Research, London : ScientistConception and Project management in Oncology and Cell Aging/ Senescence.Team management of 2-3 scientists.1995 - 1995 Sanofi-Synthelabo: Oxaliplatin Preclinical experiments in Vitro and Ex-Vivo for dossier submission. EducationJanuary 2006IGR Certificate in Chemotherapy and Medical Treatments of Cancer2001-2003Part-time Executive MBA, ESSEC, Paris.1992-1997PhD in cellular and Molecular Oncology, University Pierre et Marie Curie, Paris1992-1997Cancer Research project: Epithelial Gastric and Intestinal Cell Differentiation, compatibility with Cell Immortalization and TransformationFrench and international funds obtained (ARC, Ligue, Fondation pour la Recherche contre le Cancer, International Cooperation fellowship, Association Claude Bernard)Partnership with: Friedrich Miescher Institut, Ciba Geigy, Basel Suisse.Blood and tumor diseases department at Hôpital Paul Brousse, ParisGeneral Hospital and Harvard Medical school, Boston, Massachusetts, USADepartment of surgery, Montreal General Hospital Research Institute, Quebec1991-1992Master (DEA) in Cellular and Molecular Physiopathology of Nutritional and Inflammatory Diseases, Pierre & Marie Curie University, Paris1987- 1991MSC in Biochemistry, Pierre & Marie Curie University, ParisOther Experiences2003- 2005Executive Comity Member of ESSEC MBA alumni1997- 2000Meetings organization for a group of PhDs in Biology, in Paris and London. 1994- 1996Week ends and vacations with disabled children, Association des quatre chemins.Professor Assistant in Biochemistry and Cell Biology (part-time)1996 - 1997DIAGONALE: School for Medicine and Pharmacy exams preparation.1994 - 1995CNAM : Conservatoire National des Arts et Métiers University, Paris. 1993 - 1994APES: Preparation and training of medical and pharmacy students for Exams OthersLanguages:French: mother language- English: fluent - Arabic: Fluent Spanish: working basis |
| Activité | Alliances in Preclinical Research and translational Medecine |
| Compétences | Preclinical Research and translational Medecine (PhD)Marketing (MBA)Business DevelopmentMedical Affairs |









